The U.S. Food and Drug Administration has recently approved only the 2nd trial in the world that will involve using human embryonic stem cells in living patients. The trial is to involved people with Stargardt’s macular dystrophy, a condition that affects the vision of sufferers, who will gradually become blind as their eyesight deteriorates. Christopher […]